516 related articles for article (PubMed ID: 28465158)
1. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
[TBL] [Abstract][Full Text] [Related]
2. Antigenic Drift Defines a New D4 Subgenotype of Measles Virus.
Muñoz-Alía MÁ; Muller CP; Russell SJ
J Virol; 2017 Jun; 91(11):. PubMed ID: 28356529
[TBL] [Abstract][Full Text] [Related]
3. Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies.
Lech PJ; Tobin GJ; Bushnell R; Gutschenritter E; Pham LD; Nace R; Verhoeyen E; Cosset FL; Muller CP; Russell SJ; Nara PL
PLoS One; 2013; 8(1):e52306. PubMed ID: 23300970
[TBL] [Abstract][Full Text] [Related]
4. Measles Virus Hemagglutinin Protein Epitopes: The Basis of Antigenic Stability.
Tahara M; Bürckert JP; Kanou K; Maenaka K; Muller CP; Takeda M
Viruses; 2016 Aug; 8(8):. PubMed ID: 27490564
[TBL] [Abstract][Full Text] [Related]
5. Generation of a More Immunogenic Measles Vaccine by Increasing Its Hemagglutinin Expression.
Julik E; Reyes-Del Valle J
J Virol; 2016 Jun; 90(11):5270-5279. PubMed ID: 26984727
[TBL] [Abstract][Full Text] [Related]
6. Measles viruses of genotype H1 evade recognition by vaccine-induced neutralizing antibodies targeting the linear haemagglutinin noose epitope.
Finsterbusch T; Wolbert A; Deitemeier I; Meyer K; Mosquera MM; Mankertz A; Santibanez S
J Gen Virol; 2009 Nov; 90(Pt 11):2739-2745. PubMed ID: 19625457
[TBL] [Abstract][Full Text] [Related]
7. Functional and structural characterization of neutralizing epitopes of measles virus hemagglutinin protein.
Tahara M; Ito Y; Brindley MA; Ma X; He J; Xu S; Fukuhara H; Sakai K; Komase K; Rota PA; Plemper RK; Maenaka K; Takeda M
J Virol; 2013 Jan; 87(1):666-75. PubMed ID: 23115278
[TBL] [Abstract][Full Text] [Related]
8. Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?
Santibanez S; Niewiesk S; Heider A; Schneider-Schaulies J; Berbers GAM; Zimmermann A; Halenius A; Wolbert A; Deitemeier I; Tischer A; Hengel H
J Gen Virol; 2005 Feb; 86(Pt 2):365-374. PubMed ID: 15659756
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-induced neutralizing antibodies bind to the H protein of a historical measles virus.
Zemella A; Beer K; Ramm F; Wenzel D; Düx A; Merkel K; Calvignac-Spencer S; Stern D; Dorner MB; Dorner BG; Widulin N; Schnalke T; Walter C; Wolbert A; Schmid BG; Mankertz A; Santibanez S
Int J Med Microbiol; 2024 Mar; 314():151607. PubMed ID: 38367508
[TBL] [Abstract][Full Text] [Related]
10. Antibody neutralization of retargeted measles viruses.
Lech PJ; Pappoe R; Nakamura T; Tobin GJ; Nara PL; Russell SJ
Virology; 2014 Apr; 454-455():237-46. PubMed ID: 24725950
[TBL] [Abstract][Full Text] [Related]
11. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
[TBL] [Abstract][Full Text] [Related]
12. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
[TBL] [Abstract][Full Text] [Related]
13. Immunoglobulin g antibody-mediated enhancement of measles virus infection can bypass the protective antiviral immune response.
Iankov ID; Pandey M; Harvey M; Griesmann GE; Federspiel MJ; Russell SJ
J Virol; 2006 Sep; 80(17):8530-40. PubMed ID: 16912303
[TBL] [Abstract][Full Text] [Related]
14. A hemagglutinin-derived peptide-vaccine ignored by virus-neutralizing passive antibodies, protects against murine measles encephalitis.
El Kasmi KC; Theisen D; Brons NH; Ammerlaan W; Klingele M; Truong AT; Muller CP
Vaccine; 1999 May; 17(19):2436-45. PubMed ID: 10392626
[TBL] [Abstract][Full Text] [Related]
15. Genetic and antigenic characterisation of the haemagglutinin protein of measles virus strains recently circulating in the UK.
Jin L; Knowles WA; Rota PA; Bellini WJ; Brown DW
Virus Res; 1998 May; 55(1):107-13. PubMed ID: 9712517
[TBL] [Abstract][Full Text] [Related]
16. Depletion of measles virus glycoprotein-specific antibodies from human sera reveals genotype-specific neutralizing antibodies.
de Swart RL; Yüksel S; Langerijs CN; Muller CP; Osterhaus ADME
J Gen Virol; 2009 Dec; 90(Pt 12):2982-2989. PubMed ID: 19710253
[TBL] [Abstract][Full Text] [Related]
17. Comparison of neutralizing antibody titers against outbreak-associated measles genotypes (D4, H1 and B3) in Iran.
Fatemi Nasab GS; Salimi V; Abbasi S; Adjami Nezhad Fard F; Mokhtari Azad T
Pathog Dis; 2016 Nov; 74(8):. PubMed ID: 27777263
[TBL] [Abstract][Full Text] [Related]
18. A Recombinant Measles Vaccine with Enhanced Resistance to Passive Immunity.
Julik E; Reyes-Del Valle J
Viruses; 2017 Sep; 9(10):. PubMed ID: 28934110
[TBL] [Abstract][Full Text] [Related]
19. Protection against measles virus encephalitis by monoclonal antibodies binding to a cystine loop domain of the H protein mimicked by peptides which are not recognized by maternal antibodies.
Ziegler D; Fournier P; Berbers GA; Steuer H; Wiesmüller KH; Fleckenstein B; Schneider F; Jung G; King CC; Muller CP
J Gen Virol; 1996 Oct; 77 ( Pt 10)():2479-89. PubMed ID: 8887481
[TBL] [Abstract][Full Text] [Related]
20. Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles.
Pan CH; Valsamakis A; Colella T; Nair N; Adams RJ; Polack FP; Greer CE; Perri S; Polo JM; Griffin DE
Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11581-8. PubMed ID: 16037211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
